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Initiation, Promotion, and Inhibition of
Carcinogenesis in Rainbow Trout
by George Bailey,* Daniel Selivonchick,* and
Jerry Hendricks*
The identification of etiological agents in feral fish neoplasia epizootics has been hampered in part by
the lack of suitable fish models, and complicated by the likely existence of environmental agents which
can act to stimulate or reduce population responses to genotoxin insult. The response of fish to tumor
inhibitors and promoters, and the underlying mechanisms ofmodulation, have been studied in the rainbow
trout model. Dietary treatment of trout with the compounds indole-3-carbinol (13C), ,8-naphthofiavone
(BNF), or the polychlorinated biphenyl (PCB) complex Aroclor 1254, before and during exposure to
afiatoxin B1 (AFB1), was shown to reduce the final incidence ofhepatocellular carcinoma after 12 months,
compared to fish receiving AFB1 only. By contrast, treatment of trout with BNF or I3C following AFB1
initiation led to a significant enhancement ofultimate tumor response. Similarly, simultaneous treatment
oftrout with PCB and the carcinogenN-nitrosodiethylamine led to syncarcinogenic enhancement, rather
than inhibition, of tumor response.
Mechanisms of inhibition of AFB1 carcinogenesis by PCB, BNF, and 13C were investigated. PCB and
BNF, but not I3C, are known to be strong inducers of trout cytochrome P448 and associated activities.
Dietary induction by BNF or PCB was shown to be accompanied in isolated hepatocytes by considerably
altered AFB1 metabolism, and bysignificantly reduced rates ofDNA adduct formation forall three agents.
All agents differentially altered in vivo AFB1 pharmacokinetics, enhanced bile elimination of AFB1 as
the aflatoxicol-Ml glucuronide, and significantly reduced peak levels of liver DNA adduct formation. No
effects were seen on repair of AFB1-DNA adducts, which was very slow in trout. Detailed studies dem-
onstrated that glutatione detoxication of the AFB1.2,3-oxide is not a significant pathway in trout fed
control or inhibitor diets. The precise means by which 13C reduces adductformation are presently unclear.
Introduction
Aquatic pollutants including polycyclic aromatic hy-
drocarbons and nitrogen heterocycles have been asso-
ciated with elevated incidences ofneoplasia in feral fish
populations (1-3). However, direct demonstration of
causal relationships remain to be established. While a
number of studies have demonstrated the responsive-
ness oflaboratory fish tocarcinogens, most studies have
concentrated on carcinogens such as aflatoxin B1
(AFB1) and N-nitrosodiethylamine (DEN), which have
more relevance to neoplasia in man than in feral fish
(4,5). An exception is the environmental pollutant
benzo(a)pyrene (BP), which was recently shown to be
carcinogenic to rainbow trout (6).
Identification of etiological agents in feral fish neo-
plasia is further complicated by the almost certain pres-
ence of compounds which may act as modulators (pro-
moters, inhibitors, cocarcinogens) of environmental
carcinogen response. Recent studies have begun to ex-
amine the possible effects on tumor response and mech-
anisms of action of carcinogenesis modulators in fish.
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We review here the studies of carcinogenesis and its
modulation in a convenient laboratory fish model, the
rainbow trout. Most of these studies have examined
modulation of AFB1 hepatocarcinogenesis by polychlo-
rinated biphenyls (PCBs) and other agents. AFB1, a
highly potent mycotoxin, was initially identified as a
human carcinogen following its discovery as the etio-
logical agent in outbreaks of hepatocellular carcinoma
in trout hatcheries (7). Though it is a dietary rather
than an aquatic pollutant, studies on AFB1 carcinogen-
esis modulation in trout by PCB and other agents do
serve to indicate the extent to which carcinogenesis by
genotoxic pollutants may be modulated in fish, and the
possible mechanisms through which modulation can oc-
cur. Clearly, there is a need for similar studies using
BP and other carcinogens directly relevant to the
aquatic environment.
Tumor Studies in Trout and Other
Laboratory Fish Models
The response of rainbow trout and other laboratory
fish models to known mammalian carcinogens has been
recently reviewed (4,5,8,9), and will only be summa-BAILEY, SELIVONCHICK, AND HENDRICKS
rizedhere. Carcinogenclassestestedhaveincluded: my-
cotoxins; polycyclic aromatic hydrocarbons (PAHs); ni-
trosamines, nitrosamides, and other alkylating agents;
heterocyclic amines; steroids and cyclic lipids; chlori-
nated hydrocarbon pesticides; and azo compounds. Sev-
eral species ofsmall aquarium fish have been tested for
carcinogen response. Early studies of the zebra danio
(Brachydanio rer?io) and the guppy (Lebistes reticula-
tus) (10-17), and later experiments with the Japanese
medaka (Oryzias latipes), the species Poeciliopsis, and
other aquarium fish (18-23), have revealed liver to be
a major target organ and hepatocellular carcinoma to
be the most prevalent tumor type in fish carcinogenic
response. Hepatocellular carcinoma is also the most
common neoplastic response in trout (9, 24-28), though
otherneoplasms, includingnephroblastoma, gastric and
swim bladder papillary adenoma, and fibrosarcoma can
be induced, depending on carcinogen used, exposure
route, and dose. For example, dietary exposure to N-
methyl-N'-nitro-N-nitrosoguanidine (MNNG) induces
only gastric papillary adenomas in rainbow trout,
whereas embryonic or fry water exposure to a solution
ofMNNG also induces hepatocellular carcinoma, neph-
roblastoma, and swim bladder papillary adenoma (8).
The malignancy of some of these neoplasms has been
demonstrated bytransplantationintoisogenichosts(29,
and Hendricks and Bailey, unpublished results). Asum-
mary of all reported tissue lesions in aquatic animals
resulting from controlled xenobiotic exposures has re-
cently been compiled (30), and the histological progres-
sion of liver neoplasms in rainbow trout has been re-
viewed (31,32).
Modulation of Carcinogenesis in
Rainbow Trout
The response of rainbow trout to modulators of car-
cinogenesis depends on the initiator (carcinogen) used,
the nature and dose ofthe modulator, and the relative
timing of initiator and modulator exposure. As shown
in Table 1, experiment 1, dietary treatment with the
synthetic BNF or the naturally occurring indole 13C
before, during, and after AFB1 exposure reduces the
tumor incidence of hepatocellular carcinoma at 12
months, compared to controls receiving AFB1 alone.
This effect is also seen if 13C or BNF exposure is re-
stricted to the period before and during AFB1 treat-
ment. By contrast, exposure to these modulators after
AFB1 initiation significantly enhances tumor response
(experiment 4). Several additional compounds, includ-
ing17-,-estradiol, DDT, andcyclopropenoidfattyacids,
can promote hepatocellular carcinoma and other tumor
types, followinginitiationbyAFB1 orothercarcinogens
in trout (25,36,37, and Hendricks and Bailey, unpub-
lished results).
The ability ofcompounds to inhibit carcinogenesis in
trout can be observed over arange ofcarcinogen doses.
Experiment 2, Table 1, shows that coexposure oftrout
to AFB1 and the PCB Aroclor 1254 results in a parallel
shift in the AFB1 dose-response curve toward higher
AFB1 dose. Higher doses of Aroclor have been shown
to provide more extensive inhibition of AFB1 carcino-
genesis (38). However, PCBs do not provide universal
protection against all carcinogens in trout. As shown in
experiment 3, coexposure to Aroclors 1254 or 1242 ac-
tually enhances DEN hepatocarcinogenesis in trout. In
this context it is interesting that the incidence of neo-
plasias in English sole in the Puget Sound shows a neg-
ative correlation with PCB levels in the sediment (39),
suggesting that the initiator(s) ofthese tumors may be
susceptible to PCB anticarcinogenesis rather than en-
hancement. It is important to note that PCBs have not
proven to be carcinogenic to trout, or to any other fish
species to our knowledge (e.g., experiment 2 PCB con-
trol), nor have we yet demonstrated promotion of car-
cinogenesis in trout by these compounds.
Mechanisms of Tumor Modulation
in Trout
The tumor results outlined in Table 1 indicate that
modulation ofthe carcinogenic process can occurduring
the initiation or post-initiation (promotional) phases of
tumorigenesis in fish, as in mammalian test systems.
Mechanisms ofpromotion ofcarcinogenesis in trout are
currently poorly understood, and are under active in-
vestigation in our laboratory. By comparison, mecha-
nisms ofanticarcinogenesis involving the initiation pro-
cess have been more thoroughly studied in this model
fish system. Forexample, severalprevious studieshave
demonstrated that PCBs and BNF (33,40-43), but not
I3C (44), are potent inducers of cytochrome P448 and
associated hepatic mixed function oxidase activities in
trout. The following studies examined the extent to
which these responses could be correlated with altered
AFB1 phannacokinetics in vivo, cellular activation and
detoxicationreactions, andformationand/orpersistence
of liver DNA adducts, as possible mechanisms for in-
hibition during the initiation phase ofcarcinogenesis.
The effects of dietary modulators on cellular carcin-
ogen metabolism and mutagenesis can be readily as-
sessed usingfreshlyisolated trouthepatocytes in short-
tern culture (40,45-47). Hepatocytes have been iso-
lated from trout prefed control diet or diet containing
appropriate levels ofBNF, PCB, or I3C, and incubated
under standard conditions with [3H]AFB1. The results
ofthese studies are summarized in Table 2. The known
enzyme-inducing behavior of dietary BNF and PCB is
accompanied by major changes in AFB1 metabolism.
Both compounds cause a massive increase in the pro-
duction of the relatively less carcinogenic metabolite
aflatoxin Ml (AFM1), a substantial decrease in the pro-
ductionofthehighlycarcinogenicaflatoxicol(AFL), and
a decrease of40 to 50% in the rate offormation ofDNA
adducts, compared to control hepatocytes. The com-
pounds were not equivalent, however, since only PCB
elevated the hourly rate oftotal AFB1 metabolism. By
comparison, dietarypretreatment withI3C causedlittle
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Table 1. Modulation of hepatocarcinogenesis in rainbow trout;by tumor promoters and inhibitors.
Experiment
1. Inhibition, varying dose of
inhibitor
2
3
4
Exposure protocola
AFB1 (dietary, 20 ppb, days 57-66)
AFBj, plus BNF (50 ppm, days 1-114)
AFBj, plus BNF (500 ppm, days 1-114)
AFB1, plus 13C (1000 ppm, days 1-114)
Control diet
Inhibition, varying dose of AFB1 (1 ppb, 12 months)
carcinogen AFB1 (4 ppb, 12 months)
AFB1 (8 ppb, 12 months)
AFB, (1 ppb) plus Aroclor 1254 (50 ppm)
AFB, (4 ppb) plus Aroclor 1254 (50 ppm)
AFB, (8 ppb) plus Aroclor 1254 (50 ppm)
Aroclor 1254 (50 ppm)
Control diet
Cocarcinogenesis, different DEN (1100 ppm, 12 months)
carcinogen DEN (1100 ppm) plus Aroclor 1242
DEN (1100 ppm) plus Aroclor 1254
Inhibition or promotion, with AFB1 (20 ppb, weeks 9-12)
timing of exposure varied AFB1, plus BNF (500 ppm, weeks 1-12)
AFB1, plus BNF (500 ppm, weeks 13-24)
AFB1, plus 13C (2000 ppm, weeks 1-12)
AFB1, plus I3C (2000 ppm, weeks 13-24)
aAFBI
= Aflatoxin Bi, BNF = naphthoflavone, I3C = indole-3-carbinol, DEN =
bAll tumor incidences were taken 12 months after initiation commenced.
Tumor
incidence
45/118
21/117
7/120
5/118
0/118
27/121
68/126
98/118
14/120
38/122
88/118
0/180
0/120
12/118
37/92
25/116
9/99
1/100
30/100
1/99
51/100
diethylnitrosamine.
Table 2. AFB1-DNA binding and metabolite distribution in hepatocytes from trout fed control and inhibitor diets.
Relative distribution ofrecovered unbound isotope'
Dieta Polar AFM1 + AFL-Ml AFL AFB1 DNA adductsc Reference
Experiment 1
Control 21 (12) 2.1 (.5) 18 (4.3) 45 (20) 1.52 (.19)c (46)
BNF 29 (8.3) 31 (9) 6.2 (2.2) 33 (18) 0.96 (.4)
Experiment 2
Control 3.6 (.6) 1.6 (.3) 11 (1.2) 84 (1.5) 1.13 (.13) (48)
PCB 5.8 (.5) 27 (3) 5.2 (.9) 62 (2.9) 0.66 (.19)
Experiment 3
Control 2.6 (.4) 1.8 (.2) 8.1 (.6) 86 (1) 0.86 (.06) (49)
13C 2.6 (.3) 3.8 (.9) 7.8 (.5) 85 (1) 0.67 (.03)
aDiets were 500 ppm BNF for 6 weeks, 100 ppm Aroclor 1254 for 12 weeks, or 2,000 ppm 13C for 7 weeks. n = 7, 5, and 9 for each dietary
group in experiments 1, 2, and 3, respectively.
'Expressed as a percent oftotal isotopes recovered as aflatoxins from HPLC.
cExpressed as ,mole AFB1 adduct/gDNA/4gAFB1 metabolized. All values in parentheses represent(±+ SEM).
perturbation in production of AFB1 metabolites, but
did cause a significant decrease in DNA adduct for-
mation. Thus the three anticarcinogens appear capable
of reducing initial AFB1-DNA damage at the cellular
level, but not by the same mechanisms.
At the whole organism level, alterations in cellular
carcinogen metabolism, along with modified transport
processes or other effects, may operate to alter carcin-
ogen distribution and elimination kinetics. The effects
of PCB, I3C, and BNF on AFB1 pharmacokinetics in
trout have beenextensively studied (48,49, unpublished
results). Figure 1 summarizes some of the results of
these studies. The major effect ofall three inhibitors is
a significant increase in vivo in the rate of elimination
of AFB1 polar metabolites in bile, with I3C showing
the smallest effect. (Effects ofthese dietary compounds
on another potentially important pharnacokinetic pool,
urine, were not included and are currently under study
in our laboratory.) As in the hepatocyte studies, effects
ofthese compounds were notidentical, but werestudied
at only one dose each, that showing inhibition in the
tumor studies. Though pharmacokinetic studies are
highly laborious, it would be interesting to know ifdif-
ferencesreported here are consistentlymaintained over
a range of dietary concentrations of the three anticar-
cinogens.
The structures oftheAFB1 metabolitesfoundinrain-
bow trout bile have been previously established in our
laboratory, and found to consist almost entirely ofglu-
curonides ofAFL and AFL-M1 (50). Bile collected from
the same fish depicted in Figure 1 was analyzed on
HPLC as published (50). As summarized in Figure 2,
alterations in the levels of bile radioactivity in fish fed
control, BNF, PCB, and I3C diets were accounted for
by increases in AFL-M1 glucuronide, with 13C again
showing the smallest effect.
(%)b
(38)
(18)
(6)
(4)
(0)
(22)
(54)
(83)
(12)
(31)
(75)
(0)
(0)
(10)
(40)
(22)
(9)
(1)
(30)
(1)
(51)
Reference
(33)
(34)
(35)
(5)
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(a)
hr. Post-injection
hr. Post-injection
(c)
(b)
hr. Post-injection
FIGURE 1. Effect of dietary pretreatment with (a) BNF, (b) I3C,
or (c) PCB on AFB1 pharmacokinetics in rainbow trout. Nine-
month-old trout (55-75 g) were fed control diet or diet containing
100 ppm Aroclor 1254 (PCB), 2000 ppm I3C, or 500 ppm BNF for
8 weeks, then injected IP with [3H]AFB1 (3.8 ,uCi/2.47 [xg/25 ,uL
ethanol). Three pools ofthree fish were sacrificed at 5, 10, 16, and
24 hr, and tissues collected and frozenin liquid nitrogen and stored
at -60° C until analyzed. Tissue samples were solubilized in NCS
(Amersham), acidified with acetic acid, and counted in OCS scin-
tillant (Amersham) for tritium content. Each value is the mean of
three groups of three pooled samples, except blood, where n=9
individuals. Error bars represent SEM. These graphs are taken
from previous publications (48) and (49) and are reproduced with
permission.
We were concerned that our data did not indicate
directly the extent ofinvolvement ofglutathione (GSH)
conjugation as a detoxication pathway for AFB1 in
trout. This reaction may be especially significant since
it traps the activated AFB1-2,3-epoxide and prevents
its interaction with DNA. Since only a small percentage
of ingested AFB1 (< 13%) forms liver DNA adducts,
inhibitor-mediated alterations in even a minor amount
ofdetoxicationbythispathwaycouldbesignificant. This
reaction has further been implicated as significant in
anticarcinogenesis and species differences to AFB1
(51,52). To investigate more directly the possible role
of this pathway in trout AFB1 carcinogenesis and its
modulation, authentic AFB1-GSH conjugate was syn-
thesized and used as an HPLC marker (53). Table 3
depicts the most significant results of these studies.
Formation ofAFB1 was found not to exceed 1% oftotal
AFB1-derived metabolites in bile of trout fed control
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Im AFL-Ml Glucuronide
W AFL Glucuronide
*
_
CONTROL
*
I
*
-T1
13C /9NF
TREATMENT
cytes would also be seen invivo, and whetherinhibitors
might alter overall adduct persistence or repair. Liver
nuclei were isolated from fish fed control, PCB, or I3C
diets, and the DNA purified for determination of total
level of adducts at various times after exposure. The
results are depicted in Figure 3. As previously ob-
served, peak adduct formation occurred in control trout
24 to 48 hr afterAFB1 exposure. Dietary pretreatment
witheachoftheinhibitorssignificantly reducedthelevel
ofpeakadduct formation compared to control. [Onlythe
24-hr data point has been studied for BNF, with a re-
duction of adducts to 44% of control (8)]. Surprisingly,
I3C, the inhibitor with the weakest effects on enzyme
*1
PCB
FIGURE 2. Bile aflatoxin metabolites from the gall bladder 24 hr
after IP injection ofAFB1 into trout prefed PCB, BNF, or I3C.
Samples were taken directly from fish treated in Fig. 1 and ana-
lyzed for AFB1-derived metabolites as described (50).
Table 3. Effect of dietary modulators on aflatoxin B1
glutathione and glucuronide conjugates in bile.
Percentage of each metabolite
in the HPLC profilebce
Dieta AFB1-SGc AFL-Ml-g AFL-g
Control 0.9 ± 0.8 16 ± 2.9 63 ± 3.1
BNF (500 ppm) 0.1 ± 0.1 88 ± 0.5 28 ± 2.8
I3C (2000 ppm) 0.1 ± 0.1 55 ± 7.7 36 ± 6.7
PCB (100 ppm) ND 69 ± 6.0 18 ± 5.3
aDiets were fed 3 weeks prior to AFB, injection.
bAverage ± range (n = 2, with each sample being a pool of two
individuals). Biles were taken 24 hr after IP injection of3H-AFB,.
cAFB,-SG = glutathioneconjugate ofAFBl-2, 3-oxide;AFL-Ml-
g = aflatoxicol-M, glucuronide; AFL-g = aflatoxicol glucuronide.
ND = not detectable.
or inhibitor diets (Table 3), nor could it be produced in
in vitro incubations using trout microsomes from any
source, under conditions where mouse microsomes (or
mouse-trout mixtures) produced large quantities ofthe
conjugate (53). Further, we were able to demonstrate
that diethyl maleate treatment could substantially de-
plete GSH levels in trout and coho salmon hepatocytes
without significant effect on AFB1-DNA adduct for-
mation (data not shown). We conclude that GSH con-
jugation is not an important constitutive or inducible
pathway for AFB1 detoxication in rainbow trout. The
involvement of this detoxication pathway for
benzo(a)pyrene is under investigation in this species
(Varanasi, personal communication).
The final questions to be investigated were whether
the inhibitor-mediated reduction in DNA adduct for-
mation observed in incubations with isolated hepato-
(a)
100
90
< 80
z
0
,.-70
60
E
D 50
40
30
E
20
10
Days Post-injection
CONTROL
U 2 4 6 a 10 12 14 16 Is 20 22
(b) Days Post-injection
FIGURE 3. Effect of dietary pretreatment with (a) I3C or (b) PCB
on the formation and persistence of AFB1-DNA adducts in vivo
in trout liver nuclei. Trout of 108 ± 23 g were prefed 100 ppm
Aroclor 1254 or 2000 ppm I3C for 12 weeks, injected IP with
[3H]AFB1 (3.95 ,uCi/2.0 ,ug/100 ,L ethanol), and sampled 1/2, 1,
2, 7, and 21 days later, without feeding. Liver nuclear DNA was
purified and ABF1-DNA binding determined as described (48).
Data were weight-corrected to equal dosage. Each value repre-
sents the mean (±SEM) ofthree groups of three pooled individ-
uals. These graphs are taken from previous publications (48) and
(49) and are reproduced with permission.
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induction, hepatocyte metabolism, or bile conjugate
stimulation, had the strongest effect on reduction of
DNA adduct formation in vivo. In no case was there
any indication that these compounds alter the persis-
tence of DNA adducts in vivo. Indeed, as previously
reported (8), AFB1-DNA adducts were unusually per-
sistent in trout livercompared torates ofrodentrepair.
This repair deficiency may account in part for the high
sensitivity of this species to AFB1 carcinogenesis.
Summary
Chemical pollutants are thought to be responsible for
tumor epizootics in a number of feral fish populations,
but specific etiological agents have yet to be identified.
Tumor studies in laboratory fish models provide one
approach toward identification of carcinogens, and of
environmental parameters which may influence the re-
sponse of fish to genotoxins. Extensive evidence from
tumorstudiesinmammalianmodels, and intherainbow,
suggest that a range of nongenotoxic dietary and en-
vironmental agents mayintervene in the carcinogenesis
process, to act as stimulators or inhibitors of tumor
response. Although studies of tumor modulation with
aquatic carcinogenic pollutants in fish models have not
been conducted, extensive studies of modulation of
AFB1 carcinogenesis in the rainbow trout may serve
as amodel forunderstanding mechanisms ofmodulation
in fish. Studies in this system have shown that (a) a
wide range of compounds can act as inhibitors, pro-
moters, and co-carcinogens in trout; (b) particular mod-
ulators can act alternatively as inhibitors or promoters,
depending on the carcinogen used and the relative tim-
ing ofcarcinogen and modulator exposure; (c) the mag-
nitude ofthe effect does not appear to depend critically
on carcinogens dose, but does depend on modulator
dose.
Specific studies on the mechanisms of anti-initiation
by BNF, 13C, and PCB for AFB1 carcinogenesis in
trout have shown that dietary pretreatment by each of
these three modulators leads to reduced initial forma-
tion of AFB1-DNA adducts in vivo and in vitro. The
precise mechanisms by which this is achieved differ.
BNF and PCB inhibit at least in part through induction
of cytochrome P448, and associated enhancement of
AFM1 andAFL-Mi-glucuronide detoxicationreactions.
PCB also appears to enhance overall rates of AFB1
metabolism in intact trout and in isolated hepatocytes.
I3C shows the weakest effects on these pathways but,
at the doses studied, had the strongest effects on re-
ducing DNA adduct formation. Addition of 13C itself
does not alter AFB1 metabolism or DNA binding in
control hepatocytes (49). Hence the mechanisms)
through which I3C-mediated AFB1 binding reduction
occurs are not clearly understood, but may involve di-
rect or indirect effects ofI3C metabolites on AFB1 me-
tabolism or transport.
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